A. Pommier

发表

Mechanisms that influence tumour response to VEGF-pathway inhibitors.

S. Barry, S. Wedge, N. Smith, 2014, Biochemical Society transactions.

Review Article LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly

Cheshire Sk, J. Lobaccaro, A. Trousson, 2013 .

LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly.

J. Lobaccaro, A. Trousson, S. Baron, 2013, American journal of cancer research.

Liver X receptors, lipids and their reproductive secrets in the male.

F. Saez, J. Lobaccaro, S. Baron, 2011, Biochimica et biophysica acta.

Absence of nuclear receptors for oxysterols liver X receptor induces ovarian hyperstimulation syndrome in mice.

G. Marceau, J. Lobaccaro, S. Baron, 2009, Endocrinology.

Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy

R. Swann, S. Barry, S. Wedge, 2013, Clinical Cancer Research.

A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα.

Pascal G. P. Martin, H. Guillou, F. Lasserre, 2013, Biochimie.

Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists.

C. Hotz, C. Bourquin, A. Pommier, 2020, Pharmacological research.

Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib

P. Hoff, S. Spencer, S. Morgan, 2014, British Journal of Cancer.

Bile acids alter male fertility through G‐protein‐coupled bile acid receptor 1 signaling pathways in mice

G. Marceau, S. Houten, K. Schoonjans, 2014, Hepatology.

Lxrα regulates the androgen response in prostate epithelium.

T. Esposito, J. Lobaccaro, L. Morel, 2012, Endocrinology.

Lack of Liver X Receptors Leads to Cell Proliferation in a Model of Mouse Dorsal Prostate Epithelial Cell

J. Lobaccaro, S. Baron, C. Lours-Calet, 2013, PloS one.

Dietary Cholesterol-Induced Post-Testicular Infertility

F. Saez, G. Marceau, J. Lobaccaro, 2011, PloS one.

Liver X Receptors Protect from Development of Prostatic Intra-Epithelial Neoplasia in Mice

P. Arnaud, J. Lobaccaro, A. Trousson, 2013, PLoS genetics.

Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal Cancer.

S. Barry, Paul D. Smith, J. Kendrew, 2016, Cell metabolism.

Targeting liver X receptors in human health: deadlock or promising trail?

J. Lobaccaro, S. Baron, E. Viennois, 2011, Expert opinion on therapeutic targets.

Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells

G. Marceau, J. Lobaccaro, S. Baron, 2010, Oncogene.

Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy

P. Hoff, S. Morgan, A. Pommier, 2013, British Journal of Cancer.

Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy

R. Swann, S. Barry, S. Wedge, 2013, Clinical Cancer Research.

Lxrα regulates the androgen response in prostate epithelium.

T. Esposito, J. Lobaccaro, L. Morel, 2012, Endocrinology.

Targeting liver X receptors in human health: deadlock or promising trail?

J. Lobaccaro, E. Viennois, J. Dufour, 2011, Expert opinion on therapeutic targets.

Bile acids alter male fertility through G‐protein‐coupled bile acid receptor 1 signaling pathways in mice

G. Marceau, S. Houten, K. Schoonjans, 2014, Hepatology.

Liver X receptors, lipids and their reproductive secrets in the male.

F. Saez, J. Lobaccaro, E. Viennois, 2011, Biochimica et biophysica acta.